Circulating anti-Müllerian hormone and breast cancer risk: A study in ten prospective cohorts.

MLA

Ge, Wenzhen, et al. “Circulating Anti-Müllerian Hormone and Breast Cancer Risk: A Study in Ten Prospective Cohorts.” International Journal of Cancer, vol. 142, no. 11, June 2018, pp. 2215–26. EBSCOhost, https://doi.org/10.1002/ijc.31249.

APA

Ge, W., Clendenen, T. V., Afanasyeva, Y., Koenig, K. L., Agnoli, C., Brinton, L. A., Dorgan, J. F., Eliassen, A. H., Falk, R. T., Hallmans, G., Hankinson, S. E., Hoffman-Bolton, J., Key, T. J., Krogh, V., Nichols, H. B., Sandler, D. P., Schoemaker, M. J., Sluss, P. M., Sund, M., … Zeleniuch-Jacquotte, A. (2018). Circulating anti-Müllerian hormone and breast cancer risk: A study in ten prospective cohorts. International Journal of Cancer, 142(11), 2215–2226. https://doi.org/10.1002/ijc.31249

Chicago

Ge, Wenzhen, Tess V Clendenen, Yelena Afanasyeva, Karen L Koenig, Claudia Agnoli, Louise A Brinton, Joanne F Dorgan, et al. 2018. “Circulating Anti-Müllerian Hormone and Breast Cancer Risk: A Study in Ten Prospective Cohorts.” International Journal of Cancer 142 (11): 2215–26. doi:10.1002/ijc.31249.